This is the authors' abstract. We don't add key points for this paper.
We read with great interest the study by Embacher et al., demonstrating that the Fibrosis-4 (FIB-4) score performs comparably to liver stiffness measurement (LSM) in predicting hepatocellular carcinoma (HCC) risk across two independent cohorts.1 The clinical implications are substantial: a universally accessible blood test could democratize HCC risk stratification where vibration-controlled transient elastography (VCTE) is unavailable.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: